Device Trial Radar · NCT06355791
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
May 29, 2024
Primary completion
Dec 2027
Study completion Dec 2030
Sponsor
- Lead sponsor
- Spinal Simplicity LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 9, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center open-label single arm post-market study where the purpose is to evaluate the effectiveness and safety of the market approved Spinal Simplicity Minuteman G5 MIS Fusion Plate and bone graft material in patients with degenerative conditions of the lumbar spine resulting in chronic low back pain with lower extremity symptoms and concurrent neurogenic claudication. The indication for the device under study is degenerative conditions of the lumbar spine resulting in back pain with lower extremity symptoms and neurogenic claudication.
Conditions
- Degenerative Conditions of the Lumbar Spine
- Lumbar Spinal Stenosis
- Spondylolisthesis
Interventions
Minuteman G5 DeviceDevice
The Minuteman G5 MIS Fusion Plate consists of spinous process plates and surgical instruments. Implants are made of Titanium alloy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain (Overall, Back and Leg) using NRS/numeric rating scaleTime frame: Baseline and 1-, 3-, 6- and 12-months post implantation; annually out to five years.
- Oswestry Disability Index (ODI)Time frame: Baseline and 1-, 3-, 6- and 12-months post implantation; annually out to five years.
- PROMIS 29 2.0Time frame: Baseline and 1-, 3-, 6- and 12-months post implantation; annually out to five years.
2 more outcomes with a free account
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Vista Clinical Research
Newnan, Georgia · Recruiting
Comprehensive Pain & Spine Specialists
Indianapolis, Indiana · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Not yet recruiting
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.